Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Yew, K. Su, R. Yadavilli, M. Murthy, H. Burhan (Liverpool, United Kingdom). Treating peripheral eosinophilia in asthma: Simple and effective. Eur Respir J 2013; 42: Suppl. 57, 835

Member's Comments

No comment yet.

Related content which might interest you: Implication of IL-18 in the chronic inflammation of severe refractory asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Factors associated with irreversible airway obstruction in patients with asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Poor adherence to ICS treatment in patients with chronic respiratory diseases Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Relation of hemogram parameters with asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Predictors of exacerbations in asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Phenotypic characteristics of asthma with small airways involvement Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Obesity influences inflammatory phenotype mainly in early onset severe asthmatics Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Late-onset hypereosinophilic asthma accompanied by systemic eosinophilic manifestations Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD) Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Bronchiectasis in severe uncontrolled asthma: A common feature Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Sesonal variations of severe asthma exacerbations in the US Source: International Congress 2014 – Risk factors for respiratory disease Year: 2014 Influence of obesity and nasal polyps on severe asthma Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Bronchiectasis is common in severe asthma Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016